^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    carmustine

    Company:
    Generic mfg.
    Drug class:
    DNA synthesis inhibitor, Alkylating agent
    Related drugs:
    Apply
    Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma (NCT05083754)
    Phase 1
    Sidney Kimmel Comprehensive Cancer Center at Jo...
    Recruiting
    Last update posted :
    02/24/2025
    Initiation :
    08/31/2022
    Primary completion :
    01/01/2026
    Completion :
    01/01/2027
    PD-L1 • MSI • CD8 • PD-1 • CD4 • ICOS
    |
    temozolomide • carmustine • Zynyz (retifanlimab-dlwr)
    Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCI-MATCH) (NCT02465060)
    Phase 2
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    02/06/2025
    Initiation :
    08/17/2015
    Primary completion :
    12/31/2025
    Completion :
    12/31/2025
    MSI • CD4
    |
    PD-L1 expression
    |
    Keytruda (pembrolizumab) • Opdivo (nivolumab) • Avastin (bevacizumab) • Herceptin (trastuzumab) • Lynparza (olaparib) • Mekinist (trametinib) • cisplatin • Xalkori (crizotinib) • Tagrisso (osimertinib) • Tecentriq (atezolizumab) • Gilotrif (afatinib) • Yervoy (ipilimumab) • Ibrance (palbociclib) • dasatinib • Tafinlar (dabrafenib) • carboplatin • Imfinzi (durvalumab) • Vitrakvi (larotrectinib) • Imbruvica (ibrutinib) • gemcitabine • paclitaxel • Rituxan (rituximab) • docetaxel • 5-fluorouracil • sunitinib • everolimus • Vectibix (panitumumab) • temozolomide • Koselugo (selumetinib) • Perjeta (pertuzumab) • cytarabine • Kadcyla (ado-trastuzumab emtansine) • bortezomib • doxorubicin hydrochloride • Talzenna (talazoparib) • capecitabine • Piqray (alpelisib) • Xtandi (enzalutamide) • azacitidine • Cabometyx (cabozantinib tablet) • Balversa (erdafitinib) • Gazyva (obinutuzumab) • Mektovi (binimetinib) • albumin-bound paclitaxel • cyclophosphamide • Imjudo (tremelimumab-actl) • Cyramza (ramucirumab) • pemetrexed • fulvestrant • oxaliplatin • adavosertib (AZD1775) • etoposide IV • irinotecan • Halaven (eribulin mesylate) • Xpovio (selinexor) • Conmana (icotinib) • Pemazyre (pemigatinib) • Truqap (capivasertib) • methotrexate • Zarnestra (tipifarnib) • Aliqopa (copanlisib) • fexagratinib (ABSK091) • Ninlaro (ixazomib) • pegylated liposomal doxorubicin • epirubicin • sapanisertib (CB-228) • ipatasertib (RG7440) • Caprelsa (vandetanib) • vincristine • vinorelbine tartrate • Cometriq (cabozantinib capsule) • Tabrecta (capmatinib) • spartalizumab (PDR001) • taselisib (GDC-0032) • daunorubicin • omipalisib (GSK2126458) • ulixertinib (BVD-523) • mitoxantrone • Erivedge (vismodegib) • carmustine • bendamustine • bicalutamide • leucovorin calcium • Mvasi (bevacizumab-awwb) • Vegzelma (bevacizumab-adcd) • Zepzelca (lurbinectedin) • mitomycin • Jingzhuda (entinostat) • Recentin (cediranib) • Trazimera (trastuzumab-qyyp) • melphalan • GSK2636771 • Zirabev (bevacizumab-bvzr) • defactinib (VS-6063) • goserelin acetate • Zynyz (retifanlimab-dlwr) • fludarabine IV • Ostarine (enobosarm) • avadomide (CC-122) • vistusertib (AZD2014) • Myocet (non-pegylated liposomal doxorubicin) • mesna • vinblastine • Xofigo (radium Ra-223 dichloride) • lorvotuzumab mertansine (IMGN901) • Ampligen (rintatolimod) • E6201 • Fujovee (abivertinib) • Provenge (sipuleucel-T) • TQB2440 (pertuzumab biosimilar) • relatlimab (BMS-986016) • ABP 206 (nivolumab biosimilar) • Airuituo (bevacizumab biosimilar) • BCD-178 (pertuzumab biosimilar) • Beianting (bevacizumab biosimilar) • Boyounuo (bevacizumab biosimilar) • CC-90002 • EG1206A (pertuzumab biosimilar) • GB222 (bevacizumab biosimilar) • Hanbeitai (bevacizumab biosimilar) • ImmuniCell (autologous γδ T lymphocytes) • Leukine (sargramostim) • Vasforda (bevacizumab biosimilar) • celecoxib oral • cyclophosphamide intravenous • dexamethasone injection • ieramilimab (LAG525) • levoleucovorin calcium • methotrexate IV • sapitinib (AZD8931)
    CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant (CNS-PHLAT) (NCT06687772)
    Phase 2
    Washington University School of Medicine
    Recruiting
    Last update posted :
    01/22/2025
    Initiation :
    01/16/2025
    Primary completion :
    07/31/2027
    Completion :
    07/31/2029
    CD34
    |
    carmustine • melphalan • thiotepa
    Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (P+R-ICE) (NCT05221645)
    Phase 2
    University of Southampton
    Active, not recruiting
    Last update posted :
    12/05/2024
    Initiation :
    06/27/2022
    Primary completion :
    05/30/2026
    Completion :
    12/31/2026
    CD20
    |
    CD34 positive
    |
    Keytruda (pembrolizumab) • carboplatin • Rituxan (rituximab) • cytarabine • ifosfamide • etoposide IV • carmustine
    CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1. (EATL-001) (NCT03217643)
    Phase 2
    Imagine Institute
    Completed
    Last update posted :
    06/19/2024
    Initiation :
    02/07/2018
    Primary completion :
    11/21/2022
    Completion :
    05/15/2023
    TNFRSF8
    |
    TNFRSF8 positive
    |
    Adcetris (brentuximab vedotin) • carmustine
    Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02443077)
    Phase 3
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    06/07/2024
    Initiation :
    10/12/2016
    Primary completion :
    05/10/2025
    Completion :
    05/10/2025
    MYC • BCL2 • BCL6 • TNFA • CARD11 • TNFAIP3 • CD79A • GSTT1
    |
    CD79A mutation + CD79B mutation
    |
    Imbruvica (ibrutinib) • cytarabine • cyclophosphamide • etoposide IV • carmustine • melphalan • Starasid (cytarabine ocfosfate) • cyclophosphamide intravenous
    Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma (NCT02342782)
    Phase 1
    City of Hope Medical Center
    Active, not recruiting
    Last update posted :
    03/19/2024
    Initiation :
    06/08/2020
    Primary completion :
    09/18/2020
    Completion :
    12/31/2024
    ALK • CD34
    |
    cytarabine • etoposide IV • etoposide oral • carmustine • melphalan • Simulect (basiliximab)
    Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma (NCT01476839)
    Phase 1
    City of Hope Medical Center
    Active, not recruiting
    Last update posted :
    03/19/2024
    Initiation :
    11/09/2012
    Primary completion :
    07/24/2021
    Completion :
    12/31/2024
    CD34
    |
    cytarabine • etoposide IV • carmustine • melphalan • Simulect (basiliximab)
    Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects (NCT03382977)
    Phase 1/2
    VBI Vaccines Inc.
    Recruiting
    Last update posted :
    03/15/2024
    Initiation :
    12/06/2017
    Primary completion :
    07/01/2025
    Completion :
    08/01/2025
    MGMT
    |
    lomustine • carmustine • VBI-1901
    Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance (LYMA-101) (NCT02896582)
    Phase 2
    The Lymphoma Academic Research Organisation
    Active, not recruiting
    Last update posted :
    03/15/2024
    Initiation :
    10/01/2016
    Primary completion :
    03/01/2019
    Completion :
    03/01/2025
    CD20 • CCND1 • CD5
    |
    Chr t(11;14) • CD20 expression • CCND1 expression
    |
    cisplatin • cytarabine • Gazyva (obinutuzumab) • etoposide IV • dexamethasone • carmustine • melphalan
    hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) (NCT05052957)
    Phase 2
    Leland Metheny
    Recruiting
    Last update posted :
    02/28/2024
    Initiation :
    01/20/2023
    Primary completion :
    06/01/2024
    Completion :
    12/01/2024
    IDH1 • MGMT
    |
    IDH2 mutation • IDH wild-type • MGMT expression
    |
    temozolomide • carmustine • Neupogen (filgrastim)
    Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma (NCT00641381)
    Phase 1
    City of Hope Medical Center
    Active, not recruiting
    Last update posted :
    02/22/2024
    Initiation :
    05/10/2000
    Primary completion :
    12/30/2024
    Completion :
    12/30/2024
    CD34
    |
    cyclophosphamide • etoposide IV • carmustine • cyclophosphamide intravenous
    CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies (NCT00968760)
    Phase 1
    M.D. Anderson Cancer Center
    Completed
    Last update posted :
    12/19/2023
    Initiation :
    06/20/2011
    Primary completion :
    04/23/2020
    Completion :
    04/23/2020
    IL2
    |
    cytarabine • etoposide IV • carmustine • melphalan • Proleukin (aldesleukin) • Depocyte (liposomal cytarabine)
    A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant (NCT05540340)
    Phase N/A
    Memorial Sloan Kettering Cancer Center
    Recruiting
    Last update posted :
    12/11/2023
    Initiation :
    09/09/2022
    Primary completion :
    09/01/2024
    Completion :
    09/01/2024
    CD34
    |
    cytarabine • carmustine • melphalan
    Auto Stem Cell Transplant for Lymphoma Patients (NCT03125642)
    Phase 2
    Masonic Cancer Center, University of Minnesota
    Recruiting
    Last update posted :
    11/02/2023
    Initiation :
    04/20/2017
    Primary completion :
    09/30/2025
    Completion :
    04/30/2026
    ALK • CD4 • TCL1A
    |
    ALK positive
    |
    cytarabine • cyclophosphamide • etoposide IV • carmustine • melphalan • Depocyte (liposomal cytarabine) • Neupogen (filgrastim) • cyclophosphamide intravenous
    Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma (NCT00574509)
    Phase 1
    University of Nebraska
    Completed
    Last update posted :
    10/10/2023
    Initiation :
    03/04/1996
    Primary completion :
    11/01/2014
    Completion :
    12/10/2014
    CD20
    |
    CD20 expression
    |
    cytarabine • etoposide IV • carmustine • melphalan
    Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463)
    Phase 1/2
    University of Nebraska
    Completed
    Last update posted :
    10/09/2023
    Initiation :
    11/12/2009
    Primary completion :
    07/27/2017
    Completion :
    07/27/2018
    ALK • CD34
    |
    ALK negative
    |
    Rituxan (rituximab) • lenalidomide • cytarabine • etoposide IV • carmustine • melphalan • Truxima (rituximab-abbs) • Riabni (rituximab-arrx) • GB241 (rituximab biosimilar) • Novex (rituximab biosimilar) • Starasid (cytarabine ocfosfate)
    Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma (NCT00080886)
    Phase 2
    University of Nebraska
    Completed
    Last update posted :
    10/06/2023
    Initiation :
    05/08/2002
    Primary completion :
    11/01/2005
    Completion :
    03/12/2015
    CD20
    |
    CD20 positive
    |
    Rituxan (rituximab) • cytarabine • etoposide IV • carmustine • melphalan • Gliadel Wafer (carmustine implant) • captisol-enabled melphalan
    VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma (NCT00571493)
    Phase 1/2
    University of Nebraska
    Completed
    Last update posted :
    09/28/2023
    Initiation :
    04/14/2006
    Primary completion :
    11/01/2014
    Completion :
    11/01/2014
    CD34
    |
    cytarabine • bortezomib • etoposide IV • carmustine • melphalan
    Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma (NCT00572013)
    Phase 1/2
    University of Nebraska
    Completed
    Last update posted :
    09/07/2023
    Initiation :
    05/12/1998
    Primary completion :
    01/01/2001
    Completion :
    09/18/2009
    CD20
    |
    CD20 positive
    |
    Rituxan (rituximab) • cytarabine • carmustine
    Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00007852)
    Phase 2
    University of Nebraska
    Completed
    Last update posted :
    09/01/2023
    Initiation :
    09/01/2000
    Primary completion :
    01/01/2002
    Completion :
    01/01/2011
    CD20
    |
    CD20 positive
    |
    Rituxan (rituximab) • cytarabine • etoposide IV • carmustine • melphalan
    Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma (NCT00006695)
    Phase 2
    University of Nebraska
    Completed
    Last update posted :
    09/01/2023
    Initiation :
    04/01/2000
    Primary completion :
    09/01/2005
    Completion :
    12/16/2014
    CD20 • CD34
    |
    cytarabine • etoposide IV • carmustine • melphalan • Bexxar (iodine I 131 tositumomab) • captisol-enabled melphalan
    Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant (NCT02797470)
    Phase 1/2
    AIDS Malignancy Consortium
    Active, not recruiting
    Last update posted :
    08/01/2023
    Initiation :
    06/23/2016
    Primary completion :
    05/13/2021
    Completion :
    06/30/2025
    ALK • CD4
    |
    ALK positive
    |
    cytarabine • etoposide IV • carmustine • melphalan • Starasid (cytarabine ocfosfate)
    A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL (NCT05931263)
    Phase 3
    The First Affiliated Hospital with Nanjing Medi...
    Recruiting
    Last update posted :
    07/04/2023
    Initiation :
    06/01/2023
    Primary completion :
    02/01/2026
    Completion :
    02/01/2028
    CD34
    |
    cytarabine • etoposide IV • Epidaza (chidamide) • carmustine • melphalan
    A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma (NCT01908777)
    Phase 2
    Memorial Sloan Kettering Cancer Center
    Active, not recruiting
    Last update posted :
    06/30/2023
    Initiation :
    07/16/2013
    Primary completion :
    07/01/2024
    Completion :
    07/01/2024
    CD34
    |
    cytarabine • etoposide IV • carmustine • Istodax (romidepsin) • melphalan
    Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma (NCT05922384)
    Phase N/A
    Affiliated Hospital of Guangdong Medical Univer...
    Recruiting
    Last update posted :
    06/28/2023
    Initiation :
    07/05/2023
    Primary completion :
    09/10/2025
    Completion :
    04/10/2026
    CD34 • CD4
    |
    cytarabine • etoposide IV • carmustine • melphalan
    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma (NCT04871607)
    Phase 2
    City of Hope Medical Center
    Recruiting
    Last update posted :
    06/22/2023
    Initiation :
    11/02/2021
    Primary completion :
    10/02/2027
    Completion :
    10/02/2027
    CD34
    |
    cytarabine • etoposide IV • carmustine • melphalan • Simulect (basiliximab) • Starasid (cytarabine ocfosfate)
    Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL (NCT05863845)
    Phase N/A
    Ruijin Hospital
    Not yet recruiting
    Last update posted :
    05/18/2023
    Initiation :
    06/01/2023
    Primary completion :
    11/30/2024
    Completion :
    11/30/2025
    BCL2
    |
    BCL2 positive
    |
    Venclexta (venetoclax) • cytarabine • etoposide IV • carmustine • melphalan
    SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells (NCT04150042)
    Phase 1
    General Oncology, Inc.
    Recruiting
    Last update posted :
    04/25/2023
    Initiation :
    01/13/2021
    Primary completion :
    12/01/2025
    Completion :
    12/01/2025
    HER-2 • BRCA1 • BRCA2
    |
    BRCA2 mutation • BRCA1 mutation • HER-2 negative • PALB2 mutation
    |
    carmustine • melphalan • Mustargen (mechlorethamine)
    Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma (NCT05228249)
    Phase 1
    Fred Hutchinson Cancer Center
    Withdrawn
    Last update posted :
    01/13/2023
    Initiation :
    04/01/2023
    Primary completion :
    10/01/2025
    Completion :
    10/01/2027
    BCL2 • BCL6
    |
    cytarabine • etoposide IV • carmustine • melphalan • Zynlonta (loncastuximab tesirine-lpyl) • Starasid (cytarabine ocfosfate)
    Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma (NCT00712582)
    Phase 2
    Memorial Sloan Kettering Cancer Center
    Completed
    Last update posted :
    06/21/2022
    Initiation :
    07/01/2008
    Primary completion :
    03/12/2021
    Completion :
    03/12/2021
    CD20
    |
    CD20 expression
    |
    carboplatin • Rituxan (rituximab) • cyclophosphamide • ifosfamide • etoposide IV • mitoxantrone • carmustine
    Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects (NCT03629873)
    Phase 2
    The First Affiliated Hospital with Nanjing Medi...
    Active, not recruiting
    Last update posted :
    01/03/2022
    Initiation :
    02/01/2018
    Primary completion :
    12/31/2021
    Completion :
    12/31/2021
    ALK • CD34
    |
    ALK positive
    |
    cytarabine • cyclophosphamide • etoposide IV • Epidaza (chidamide) • carmustine
    Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) (NCT00329030)
    Phase 3
    National Heart, Lung, and Blood Institute (NHLBI)
    Completed
    Last update posted :
    11/01/2021
    Initiation :
    12/01/2005
    Primary completion :
    08/01/2013
    Completion :
    08/01/2013
    CD20 • CD8 • IL2RA • PTPRC • NCAM1 • ISG20
    |
    Rituxan (rituximab) • cytarabine • etoposide IV • carmustine • melphalan • Bexxar (iodine I 131 tositumomab)
    Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma (OSU-17225) (NCT03583424)
    Phase 1/2
    Ohio State University Comprehensive Cancer Center
    Active, not recruiting
    Last update posted :
    10/06/2021
    Initiation :
    09/10/2018
    Primary completion :
    12/31/2022
    Completion :
    12/31/2022
    BCL2 • CD34
    |
    Venclexta (venetoclax) • cytarabine • etoposide IV • carmustine • melphalan • Starasid (cytarabine ocfosfate)
    Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT00350181)
    Phase 2
    Stanford University
    Completed
    Last update posted :
    09/23/2021
    Initiation :
    08/01/2006
    Primary completion :
    08/01/2007
    Completion :
    04/01/2010
    HLA-DRB1 • HLA-B
    |
    cyclophosphamide • etoposide IV • sirolimus • carmustine • busulfan • cyclophosphamide intravenous
    High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601)
    Phase N/A
    Roswell Park Cancer Institute
    Completed
    Last update posted :
    04/22/2021
    Initiation :
    06/29/2006
    Primary completion :
    07/09/2018
    Completion :
    07/09/2018
    CD4
    |
    carboplatin • cyclophosphamide • etoposide IV • carmustine • melphalan • thiotepa • busulfan • cyclophosphamide intravenous
    Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma (NCT02059239)
    Phase 1/2
    Weill Medical College of Cornell University
    Completed
    Last update posted :
    02/21/2021
    Initiation :
    06/04/2014
    Primary completion :
    12/16/2019
    Completion :
    06/15/2020
    CD34
    |
    Rituxan (rituximab) • cytarabine • etoposide IV • Campath (alemtuzumab) • carmustine • bendamustine • melphalan
    SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00004031)
    Phase 3
    Southwest Oncology Group
    Completed
    Last update posted :
    02/02/2021
    Initiation :
    07/01/1997
    Primary completion :
    06/01/2008
    Completion :
    10/31/2013
    CD20
    |
    Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • prednisone • carmustine • cyclophosphamide intravenous
    Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation (NCT00591630)
    Phase 2
    M.D. Anderson Cancer Center
    Completed
    Last update posted :
    02/02/2021
    Initiation :
    11/14/2007
    Primary completion :
    03/05/2020
    Completion :
    03/05/2020
    CD20 • CD34
    |
    CD20 positive
    |
    Rituxan (rituximab) • cytarabine • etoposide IV • carmustine • melphalan • Zevalin (ibritumomab tiuxetan) • Depocyte (liposomal cytarabine)